Join the Iron Deficiency Anemia group to help and get support from people like you.
Iron Deficiency Anemia News
Related terms: Anemia, Iron Deficiency, Hypochromic anemia, Microcytic anemia
Maternal Anemia in Early Pregnancy May Increase Risk for Congenital Heart Disease
WEDNESDAY, April 23, 2025 – Maternal anemia in early pregnancy is associated with an increased risk for congenital heart disease (CHD) in offspring, according to a study published online April 23 in...
First-Trimester Iron Screening Can ID Women at Risk for Later Deficiency
WEDNESDAY, Oct. 2, 2024 – Screening pregnant women during their first trimester with a target ferritin concentration of >60 μg/L may identify those at risk for iron deficiency later in pregnancy, ...
Most Pregnant Women Will Become Iron Deficient, Study Finds
THURSDAY, Sept. 26, 2024 – Four out of five pregnant women will become deficient in an essential nutrient, iron, by their third trimester, a new study finds. The researchers and other experts are...
14 Percent of U.S. Adults Meet Criteria for Absolute Iron Deficiency
TUESDAY, Sept. 24, 2024 – A considerable proportion of U.S. adults has absolute and functional iron deficiency, according to a study published online Sept. 24 in JAMA Network Open. Yahya M.K....
USPSTF: Evidence Still Lacking for Iron Deficiency Screening in Pregnancy
TUESDAY, Aug. 20, 2024 – The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to weigh the balance of benefits and harms for recommending screening...
Many Cases of Iron Deficiency Go Too Long Without Proper Treatment
MONDAY, Aug. 19, 2024 – Iron deficiency isn’t being effectively treated in the United States, with low iron levels persisting for years in most patients, a new study finds. Almost 3 of 5 (58%) p...
Iron Deficiency Common, Often Persistent
THURSDAY, Aug. 15, 2024 – Iron deficiency (ID) is common in an American statewide health system, and the time to resolution is prolonged, according to a study published online Aug. 15 in Blood...
Preoperative IV Iron Treatment Better for Iron Deficiency Anemia
WEDNESDAY, Aug. 7, 2024 – For patients with preoperative iron deficiency anemia (IDA), intravenous (IV) iron treatment is associated with a significant reduction in 30-day postoperative mortality...
Prevalence of Iron Deficiency Varies With Different Definitions
MONDAY, June 10, 2024 – The prevalence of iron deficiency varies significantly with three different definitions, according to a study published online June 7 in JAMA Network Open. James C. Barton,...
Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
BASKING RIDGE, N.J. & SHIRLEY, N.Y.--(BUSINESS WIRE) June 05, 2023 --Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug...
Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ – Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Adm...
FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia
MORRISTOWN, N.J., Jan. 29, 2020 /PRNewswire/ – Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) i...
FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults
London, UK, 26 July 2019: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces that the U.S. Food and Drug...
AMAG Pharmaceuticals Announces FDA Approval of Feraheme (ferumoxytol injection) for All Eligible Adult Patients with Iron Deficiency Anemia
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label ...
FDA Approves Auryxia (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis
BOSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) – Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today announced that the U.S....